Sirtuin 1 Expression in Canine Mammary Tumors: A Pilot Study

Area of Science:

• Veterinary Medicine
• Molecular Biology
• Oncology

Background:

• Sirtuin 1 (SIRT1) is a key protein in mammalian aging and metabolism.
• SIRT1's role in cancer is debated, with evidence suggesting it can act as both an oncogene and a tumor suppressor.
• Understanding SIRT1's function in canine mammary cancer is crucial due to its potential impact on disease progression.

Purpose of the Study:

• To investigate SIRT1 expression patterns in canine mammary tissues.
• To analyze SIRT1's subcellular localization in canine mammary cancer cell lines.
• To elucidate the potential role of SIRT1 in canine mammary oncogenesis.

Main Methods:

• Immunohistochemistry was used to assess SIRT1 expression in canine mammary tissues.
• Western blot and immunofluorescence analyses were performed on canine mammary cell lines.
• Subcellular localization of SIRT1 was examined in relation to tumor differentiation.

Main Results:

• SIRT1 expression decreased progressively from normal tissue to less differentiated malignant tumors (G2-G3).
• A notable shift in SIRT1 subcellular localization from the nucleus to the cytoplasm was observed in poorly differentiated tumors.
• These findings indicate altered SIRT1 expression and localization correlate with canine mammary tumor progression.

Conclusions:

• SIRT1 expression is downregulated in advanced canine mammary tumors.
• The shift in SIRT1 localization may indicate a functional change associated with malignancy.
• Further research is warranted to fully understand SIRT1's role in canine mammary cancer development and progression.